Original Research
Published on 19 Feb 2026
Cost-effectiveness of hetrombopag, eltrombopag, and avatrombopag for chronic immune thrombocytopenia in China: a cost-utility analysis
in Health Economics
- 100 views
Original Research
Published on 19 Feb 2026
in Health Economics
Original Research
Published on 19 Feb 2026
in Ethnopharmacology
Opinion
Published on 19 Feb 2026
in Addictive Disorders
Original Research
Published on 19 Feb 2026
in Translational Pharmacology
Original Research
Published on 19 Feb 2026
in Public Health Policy
Original Research
Published on 19 Feb 2026
in Ethnopharmacology
Original Research
Published on 19 Feb 2026
in Biofabrication
Original Research
Published on 19 Feb 2026
in Cognitive Neuroscience
Opinion
Published on 19 Feb 2026
in Nutrition and Sustainable Diets
Original Research
Published on 19 Feb 2026
in Climate-Smart Food Systems
Review
Published on 19 Feb 2026
in Fungal Pathogenesis
Original Research
Published on 19 Feb 2026
in Psychology in Education
Original Research
Published on 19 Feb 2026
in Dynamics of Migration and (Im)Mobility
Perspective
Published on 19 Feb 2026
in Data Visualization
Original Research
Published on 19 Feb 2026
in One Health in Bacteriology
Systematic Review
Published on 19 Feb 2026
in Cancer Imaging and Image-directed Interventions